GoodRx Holdings, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
GoodRx Holdings, Inc. (GDRX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $1.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-05
- GoodRx Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $985.00K, a 0.61% increase year-over-year.
- GoodRx Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $925.00K, a 14.83% decline year-over-year.
- GoodRx Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $944.00K, a 21.53% decline year-over-year.
- GoodRx Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $998.00K, a 5.04% decline year-over-year.
- GoodRx Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $4.01M, a 4.23% decline from fiscal 2024.
- GoodRx Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $4.18M, a 1.95% increase from fiscal 2023.
- GoodRx Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $4.10M.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $985.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.91M 10-Q · filed 2026-08-05 | $2.85M derived: sum of 3 quarters · filed 2026-08-05 | $3.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $925.00K 10-Q · filed 2026-05-06 | $1.87M derived: sum of 2 quarters · filed 2026-05-06 | $2.87M derived: sum of 3 quarters · filed 2026-05-06 | $3.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $944.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.94M derived: sum of 2 quarters · filed 2026-02-26 | $2.92M derived: sum of 3 quarters · filed 2026-08-05 | $4.01M 10-K · filed 2026-02-26 |
| 2025-09-30 | $998.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.98M derived: sum of 2 quarters · filed 2026-08-05 | $3.06M 10-Q · filed 2025-11-04 | $4.27M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $979.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.06M 10-Q · filed 2026-08-05 | $3.27M derived: sum of 3 quarters · filed 2026-08-05 | $4.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.09M 10-Q · filed 2026-05-06 | $2.29M derived: sum of 2 quarters · filed 2026-05-06 | $3.34M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.25M derived: sum of 2 quarters · filed 2026-02-26 | $4.18M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.98M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $1.93M 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $4.10M 10-K · filed 2026-02-26 |